Leanne Kelly
Chief Financial Officer · GRI Bio, Inc.
- 2025
- Sep 18, 2025
- 2
Summary
Latest filing:
Leanne Kelly is Chief Financial Officer of GRI Bio, Inc. (GRI). 2 SEC Form 4 filings on record, most recently on 18 September 2025.
Trading pattern
InsiderAlpha's records for Leanne Kelly go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at Leanne Kelly's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Catalyst4, Inc. - $98.71M in MPLT purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- Paul A. Mahon - $93.78M in UTHR purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Leanne Kelly?
Leanne Kelly is a corporate insider, tracked as Chief Financial Officer of GRI Bio, Inc. (GRI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Leanne Kelly last file a Form 4?
The most recent primary Form 4 on record is dated 18 September 2025, one of 2 filings going back to 2025.